Boston Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.08M | Buy |
17,359
+6,568
| +61% | +$408K | 0.06% | 372 |
|
|
2019
Q2 | $768K | Sell |
10,791
-8,160
| -43% | -$581K | 0.04% | 416 |
|
|
2019
Q1 | $1.49M | Buy |
18,951
+9,811
| +107% | +$769K | 0.08% | 266 |
|
|
2018
Q4 | $774K | Buy |
9,140
+777
| +9% | +$65.8K | 0.04% | 377 |
|
|
2018
Q3 | $1.43M | Sell |
8,363
-104
| -1% | -$17.8K | 0.06% | 317 |
|
|
2018
Q2 | $1.09M | Buy |
+8,467
| New | +$1.09M | 0.03% | 362 |
|